Treating diseases with cord blood: ethical stem-cell process gets FDA approval

Sid Hastings
Related Articles: 
The St. Louis Cord Blood Bank at SSM Cardinal Glennon Children's Medical Center has received licensure approval from the U.S. Food and Drug Administration to manufacture and distribute cord blood-derived stem-cell products, making it the first blood bank in the region and only the fourth in the world to earn this distinction.

A subscription is required to access this content.

Current online and print subscribers, click here to login and view this article.

Please click here to subscribe to the St. Louis Review. You may subscribe to the online edition only or both the online and print editions.

If you already have a subscription and are still unable to access this information, please contact the St. Louis Review.

Why does the St. Louis Review require a subscription to access content online? (Click to view).

No votes yet